COO - NASDAQ NMS - GLOBAL MARKET
Industry: Health Care
Market Cap: 16.6 B
IPO Date: Jan 21, 1983
Country: US
Currency: USD
Shares Outstanding: 200.0 M
5/16/2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 6.7%. This drop was discouraging since the S&P 500 held steady.
Source: Yahoo
5/14/2025
XRAY vs. COO: Which Stock Is the Better Value Option?
Source: Yahoo
5/14/2025
Cooper Companies (NASDAQ:COO) has had a rough three months with its share price down 11%. It seems that the market...
Source: Yahoo
5/14/2025
We recently published a list of 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying. In this article, we are going to take a look at where The Cooper Companies, Inc. (NASDAQ:COO) stands against other small-cap healthcare stocks hedge funds are buying. The U.S. healthcare sector has performed better in 2025 compared to the broader market. […]
Source: Yahoo
5/8/2025
SAN RAMON, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the William Blair Growth Stock Conference on Thursday, June 5, 2025. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled at 11:20 AM CT. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://
Source: Yahoo
5/8/2025
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Source: Yahoo
5/6/2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Source: Yahoo
4/30/2025
SAN RAMON, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Barbara Carbone as an independent director, effective May 1, 2025. Ms. Carbone has also been appointed to serve on the Audit Committee when she joins the Board. Ms. Carbone brings nearly four decades of experience across a wide variety of industries. She spent most of her career at KPMG LLP, from 1981-2019, where s
Source: Yahoo
4/29/2025
SAN RAMON, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report second quarter 2025 financial results on Thursday, May 29, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 1515103. A simultaneous audio webcast and subsequent replay c
Source: Yahoo
4/22/2025
HOUSTON - The Wyatt Foundation and The Conceive Fertility Foundation announce today the launch of their 2025 IVF grant program, which will award $15,000 grants to five individuals/couples who need in...
Source: Finnhub
4/8/2025
As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...
Source: Yahoo
4/3/2025
CooperCompanies’s stock price has taken a beating over the past six months, shedding 24.6% of its value and falling to $80.68 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Source: Yahoo
3/17/2025
We came across a bullish thesis on The Cooper Companies, Inc. (NASDAQ:COO) on ValueInvestorsClub by dsteiner84. In this article, we will summarize the bulls’ thesis on COO. The company’s shares were trading at $98.10 when this thesis was published, vs. the closing price of $81.22 on Mar 14. COO develops, manufactures, and markets contact lens […]
Source: Yahoo
3/14/2025
The Cooper Companies (NasdaqGS: COO) experienced a 14.56% decline in its share price last week following its recent earnings announcement. Notably, the company reported solid growth, with first-quarter sales increasing to $964.7 million and net income rising to $104.3 million. While positive from an operational standpoint, the updated earnings guidance did not seem to bolster investor confidence, possibly contributing to the share price fall. The broader market trends over the same week...
Source: Yahoo
3/13/2025
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including CooperCompanies (NASDAQ:COO) and its peers.
Source: Yahoo
3/12/2025
The fund lagged in the fourth quarter but outperformed its benchmark for the year. Read more here.
Source: SeekingAlpha
3/8/2025
We recently compiled a list of the 10 Stocks Trade Weaker on Disappointing News. In this article, we are going to take a look at where The Cooper Companies, Inc. (NASDAQ:COO) stands against the other stocks. Wall Street finished the trading week on a strong note, with all major indices recording gains as investors digested the […]
Source: Yahoo
3/7/2025
The S&P 500 added 0.6% on Friday, March 7, after the February jobs report showed a slight recovery in hiring from the previous month.
Source: Yahoo
3/7/2025
Cooper Companies (NasdaqGS:COO) recently reported improved financials with Q1 FY2025 sales rising to $965 million and net income growing to $104 million. The company's projection for fiscal 2025 revenue suggests 6% to 8% organic growth, which could have bolstered investor sentiment, leading to the stock's 1.24% price increase over the past week. This gain is notable against a backdrop of significant market declines, with the Dow and S&P 500 both down amid tariff and economic concerns,...
Source: Yahoo